Bristlecone Advisors LLC Continues to Hold Stake in Danaher Corporation (DHR)
Bristlecone Advisors LLC continued to hold its position in shares of Danaher Corporation (NYSE:DHR) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,476 shares of the conglomerate’s stock at the end of the first quarter. Bristlecone Advisors LLC’s holdings in Danaher Corporation were worth $297,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. Peddock Capital Advisors LLC raised its position in shares of Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock worth $105,000 after buying an additional 181 shares during the last quarter. ClariVest Asset Management LLC acquired a new position in shares of Danaher Corporation during the first quarter worth about $157,000. Motco raised its position in shares of Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock worth $158,000 after buying an additional 390 shares during the last quarter. Baystate Wealth Management LLC raised its position in shares of Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock worth $163,000 after buying an additional 60 shares during the last quarter. Finally, Cedar Wealth Management LLC raised its position in shares of Danaher Corporation by 5.3% in the first quarter. Cedar Wealth Management LLC now owns 2,286 shares of the conglomerate’s stock worth $196,000 after buying an additional 115 shares during the last quarter. Hedge funds and other institutional investors own 76.12% of the company’s stock.
Shares of Danaher Corporation (DHR) traded up 0.12% during trading on Tuesday, reaching $80.70. 489,218 shares of the company traded hands. The firm’s 50-day moving average is $82.75 and its 200-day moving average is $84.26. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.01. The stock has a market capitalization of $56.06 billion, a PE ratio of 25.76 and a beta of 1.03.
Danaher Corporation (NYSE:DHR) last released its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, topping the Zacks’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The business had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.50 billion. During the same quarter in the previous year, the company earned $0.90 EPS. The business’s quarterly revenue was up 6.3% compared to the same quarter last year. On average, equities analysts predict that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another domain, it was stolen and republished in violation of international trademark and copyright laws. The original version of this piece of content can be accessed at https://www.watchlistnews.com/bristlecone-advisors-llc-continues-to-hold-stake-in-danaher-corporation-dhr/1491162.html.
A number of research analysts have issued reports on the stock. Wells Fargo & Company restated a “market perform” rating on shares of Danaher Corporation in a research report on Saturday, July 22nd. Jefferies Group LLC restated a “buy” rating and set a $95.00 target price on shares of Danaher Corporation in a research report on Friday, August 4th. BidaskClub lowered shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, July 25th. Credit Suisse Group restated a “buy” rating and set a $93.00 target price on shares of Danaher Corporation in a research report on Wednesday, May 24th. Finally, Janney Montgomery Scott lowered shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a research report on Wednesday, June 7th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Buy” and an average target price of $91.76.
In other news, SVP Angela S. Lalor sold 10,815 shares of the business’s stock in a transaction that occurred on Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total value of $910,190.40. Following the completion of the sale, the senior vice president now directly owns 39,020 shares in the company, valued at approximately $3,283,923.20. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the business’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $81.78, for a total transaction of $799,154.16. Following the completion of the sale, the insider now owns 155,520 shares of the company’s stock, valued at $12,718,425.60. The disclosure for this sale can be found here. In the last three months, insiders sold 38,623 shares of company stock valued at $3,206,426. Corporate insiders own 12.20% of the company’s stock.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.